G354-2107 Screening compound: 3-(3-methylphenyl)-N-[4-(1,2-oxazol-5-yl)phenyl]-3-(1H-pyrrol-1-yl)propanamide

G354-2107 Screening compound: 3-(3-methylphenyl)-N-[4-(1,2-oxazol-5-yl)phenyl]-3-(1H-pyrrol-1-yl)propanamide
G354-2107 Screening compound: 3-(3-methylphenyl)-N-[4-(1,2-oxazol-5-yl)phenyl]-3-(1H-pyrrol-1-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G354-2107
3-(3-methylphenyl)-N-[4-(1,2-oxazol-5-yl)phenyl]-3-(1H-pyrrol-1-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G354-2107

Molecular Formula

C23H21N3O2 (C23 H21 N3 O2)

Compound Name

3-(3-methylphenyl)-N-[4-(1,2-oxazol-5-yl)phenyl]-3-(1H-pyrrol-1-yl)propanamide

IUPAC name

3-(3-methylphenyl)-N-[4-(12-oxazol-5-yl)phenyl]-3-(1H-pyrrol-1-yl)propanamide

SMILES

Cc1cccc(C(CC(Nc(cc2)ccc2-c2ccno2)=O)n2cccc2)c1

InChI

InChI=1S/C23H21N3O2/c1-17-5-4-6-19(15-17)21(26-13-2-3-14-26)16-23(27)25-20-9-7-18(8-10-20)22-11-12-24-28-22/h2-15,21H,16H2,1H3,(H,25,27)/t21-/m0/s1

InChI Key

ZKXPGGFCRLCDFW-NRFANRHFSA-N

MDL Number (MFCD)

MFCD15001554

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

371.44

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.446

Distribution Coefficient, logD

4.446

Water Solubility, LogSw

-4.32

Polar Surface Area

48.508

Acid Dissociation Constant (pKa)

11.92

Base Dissociation Constant (pKb)

-0.02

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

13.00

G354-2107 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Targets:
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G354-2107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G354-2107?
Check Price and Availability of G354-2107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G354-2107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G354-2107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G354-2107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G354-2107 available by request